CLINICAL_TRIALS
trial_result
· 2023-03-13
Clinical Trial Update: Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder [Phase 2]
Summary
Phase 2 clinical trial evaluating safety and efficacy of psilocybin for body dysmorphic disorder has completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Body Dysmorphic Disorders | Phase 2 | Status: COMPLETED | Results posted: 2023-03-13